HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bradley, W. A. Articles by Gianturco, S. H. Search for Related Content PubMed PubMed Citation Articles by Bradley, W. A. Articles by Gianturco, S. H. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 27, 40-48, Copyright © 1986 by Lipid Research, Inc.

ARTICLES

ApoE is necessary and sufficient for the binding of large triglyceride- rich lipoproteins to the LDL receptor; apoB is unnecessary

WA Bradley and SH Gianturco

Large triglyceride-rich very low density lipoproteins (VLDL) Sf 60-400 from hypertriglyceridemic (HTG) patients, but not VLDL from normal subjects, bind to the LDL receptor of human skin fibroblasts because they contain apolipoprotein E (apoE) of the correct conformation, accessible both to the LDL receptor and to specific proteolysis by alpha-thrombin. Trypsin treatment of HTG-VLDL Sf 60-400 causes extensive apoB hydrolysis (fragments less than 100,000 mol wt), total degradation of apoE, and thus complete loss of LDL receptor binding. The reincorporation of apoE (1 mol/mol VLDL) into trypsin-treated HTG- VLDL completely restored the ability of HTG-VLDL to interact with the LDL receptor, suggesting that apoE probably does not induce a conformational change in apoB which results in receptor recognition, nor is intact apoB necessary to maintain the appropriate conformation of apoE for LDL receptor binding. As a model of large triglyceride-rich VLDL Sf greater than 60, we fractionated Intralipid by the Lindgren method of cumulative flotation and prepared apoE-Intralipid complexes. Competitive binding studies demonstrated that apoE-Intralipid is at least as effective as LDL for uptake and degradation of 125I-labeled LDL. Control Intralipid complexes containing apoA-I instead of apoE do not compete with iodinated LDL. Since these TG-rich complexes contain no apoB, apoB is, therefore, not only not sufficient for receptor- mediated uptake of large particles, it is not necessary. ApoE of the correct conformation is not only necessary but is sufficient to mediate receptor binding of large triglyceride-rich particles to the LDL receptor.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z. Zhao and P. Michaely The Epidermal Growth Factor Homology Domain of the LDL Receptor Drives Lipoprotein Release through an Allosteric Mechanism Involving H190, H562, and H586 J. Biol. Chem., September 26, 2008; 283(39): 26528 - 26537. [Abstract] [Full Text] [PDF]

				K. G. Jackson, V. Maitin, D. S. Leake, P. Yaqoob, and C. M. Williams Saturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells J. Lipid Res., February 1, 2006; 47(2): 393 - 403. [Abstract] [Full Text] [PDF]

				S. I. Malloy, M. K. Altenburg, C. Knouff, L. Lanningham-Foster, J. S. Parks, and N. Maeda Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3 Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 91 - 97. [Abstract] [Full Text] [PDF]

				J. Bjorkegren, A. Silveira, S. Boquist, R. Tang, F. Karpe, M. G. Bond, U. de Faire, and A. Hamsten Postprandial Enrichment of Remnant Lipoproteins With ApoC-I in Healthy Normolipidemic Men With Early Asymptomatic Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1470 - 1474. [Abstract] [Full Text] [PDF]

				J. Heeren, T. Grewal, S. Jackle, and U. Beisiegel Recycling of Apolipoprotein E and Lipoprotein Lipase through Endosomal Compartments in Vivo J. Biol. Chem., November 2, 2001; 276(45): 42333 - 42338. [Abstract] [Full Text] [PDF]

				H. Campos, D. Perlov, C. Khoo, and F. M. Sacks Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia J. Lipid Res., August 1, 2001; 42(8): 1239 - 1249. [Abstract] [Full Text] [PDF]

				G. Datta, D. W. Garber, B. H. Chung, M. Chaddha, N. Dashti, W. A. Bradley, S. H. Gianturco, and G. M. Anantharamaiah Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo J. Lipid Res., June 1, 2001; 42(6): 959 - 966. [Abstract] [Full Text]

				H. Relas, H. Gylling, and T. A. Miettinen Fate of intravenously administered squalene and plant sterols in human subjects J. Lipid Res., June 1, 2001; 42(6): 988 - 994. [Abstract] [Full Text]

				C. Khoo, H. Campos, H. Judge, and F. M. Sacks Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content J. Lipid Res., February 1, 1999; 40(2): 202 - 212. [Abstract] [Full Text]

				J Heeren, W Weber, and U Beisiegel Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation J. Cell Sci., January 2, 1999; 112(3): 349 - 359. [Abstract] [PDF]

				N. Mero, A. Van Tol, L. M. Scheek, T. Van Gent, C. Labeur, M. Rosseneu, and M-R. Taskinen Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities J. Lipid Res., July 1, 1998; 39(7): 1493 - 1502. [Abstract] [Full Text]

				J. Björkegren, F. Karpe, S. Vitols, P. Tornvall, and A. Hamsten Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro J. Lipid Res., February 1, 1998; 39(2): 423 - 437. [Abstract] [Full Text]

				V. Clavey, S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 963 - 971. [Abstract] [Full Text]

				B. Schwiegelshohn, J. F. Presley, M. Gorecki, T. Vogel, Y. A. Carpentier, F. R. Maxfield, and R. J. Deckelbaum Effects of Apoprotein E on Intracellular Metabolism of Model Triglyceride-rich Particles Are Distinct from Effects on Cell Particle Uptake J. Biol. Chem., January 27, 1995; 270(4): 1761 - 1769. [Abstract] [Full Text] [PDF]